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The aim of this study was to determine the effect of mycobacterial proteins on
mycobacterial bioﬁlm formation and growth processes. We separated growth-
affecting proteins (GEPs) from wild type of Mycobacterium bovis and ATCC strain
of Mycobacterium avium subsp. avium. Our results showed that these mycobacteria-
secreted GEPs are involved in bioﬁlm formation, growth stimulatory, and inhibitory
processes. Our ﬁndings suggest that GEP stimulatedM. avium subsp. avium growth in
vitro. Stimulation process was observed in mycobacteria affected with GEP extracted
from M. avium subsp. avium. We found that both GEPs inhibited the growth of the
M. bovis. Optical density measurement and visual analysis conﬁrm that GEP plays an
important role in bioﬁlm formation process. Most ofM. bovis GEP are associated with
the type VII secretion and general secretion pathways. Our results contribute to a better
understanding of the mechanisms underlying mycobacterial bioﬁlm formation and
growth-affecting processes and better characterization of mycobacterial proteins and
their functions. It is noteworthy that this ﬁnding represents the ﬁrst demonstration of
GEP-mediated growth effects on a solid and liquid medium.
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Introduction
The ability of bacteria to communicate and behave as a group for social
interactions like a multicellular organism has provided signiﬁcant beneﬁts to
bacteria in host colonization, formation of bioﬁlms, defense against competitors,
and adaptation to changing environments [1]. Many bacteria have been found to
regulate diverse physiological processes and group activities through a mechanism
called quorum sensing (QS) [2].
With the emergence of drug resistance, treating mycobacterial infections is
becoming increasingly difﬁcult and hence, looking for newer drug targets,
especially those involving QS, is an essential component of mycobacterial
research. However, the Gram-positive mycobacteria remain a mystery with no
clear evidence known about their QS mechanism [3]. Bioinformatics analysis has
revealed the presence of LuxR homologs in Mycobacterium tuberculosis, but the
experimental supports are lacking [4, 5]. Some of these homologs are ubiquitous
across the multiple mycobacterial species and are involved in mycobacterial
bioﬁlm formation or persistence, suggesting a possible existence of similar QS
mechanisms. Given the fact that bioﬁlm formation is mostly linked with QS
regulation [3], the existence of QS in mycobacteria cannot be ruled out. However,
this hypothesis needs experimental validation [6].
M. tuberculosis typically forms pellicles at the liquid–air interface in growth
media. In recent times, pellicles have been equated to bioﬁlms, because they are
held together by extracellular polymeric substance (EPS) produced by the
bacterium [7]. M. tuberculosis forms bioﬁlms harboring antibiotic-tolerant bacilli
in vitro, but the factors that induce bioﬁlm formation and the nature of the
extracellular material (ECM) that holds the cells together are poorly understood,
polysaccharides, proteins, DNA, and lipids are important components of the ECM
[8, 9]. However, the composition of the mycobacteria bioﬁlm EPS and the
mechanisms governing its formation remain poorly understood [9]. It is known
that proteinaceous components include cell surface adhesins, protein subunits of
ﬂagella, and pili, secreted extracellular proteins, and proteins of outer membrane
vesicles [10]. Better characterization of the proteinaceous components structure,
functions, and regulatory circuits controlling bioﬁlm matrix production will
provide better understanding of mycobacteria physiological processes, such as
host colonization, defense against competitors, and adaptation to changing
environments (e.g., antibiotic resistance). Understanding these mechanisms and
their controlled social activities may open a new avenue for controlling myco-
bacterial infections [1, 6, 10]. In this study, we determine the effect of mycobac-
terial proteins on mycobacteria bioﬁlm formation and growth processes. We
characterize these proteins by their gene name, status of existence, molecular
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weight, location, function, superfamily, and secretion pathway. Biggest part of
these proteins were associated with the type VII secretion (T7S) pathway.
Materials and Methods
Bacterial strains and GEP preparation
Wild type of Mycobacterium bovis and ATCC strains of Mycobacterium
avium subsp. avium (ATCC 15769) and Mycobacterium terrae (ATCC 15755)
were used throughout these studies. GEPs were extracted from M. bovis and
M. avium subsp. avium and tested in vitro: MA GEP – GEP extracted from
M. avium subsp. avium; MB GEP – GEP extracted from M. bovis. Cultures were
centrifuged (at 4 °C for 45 min at 4,000 rcf) after 8 and 16 weeks of incubation and
passed the ﬁltrate through a low protein-binding 0.2-μm ﬁlter (Dismic-13 CP
cellulose acetate ﬁlters, Advantec, Tokyo, Japan). Concentration of proteins (CP)
was quantiﬁed by Bradford assay.
Growth of bacteria
Bacterial cultures (105 CFU/ml) were transferred on Lowenstein–Jensen
medium with pyruvic acid (Becton, Dickinson and Company, http://www.bd.com/
europe/regulatory/Assets/IFU/Difco_BBL/244420.pdf). Cultures were affected by
Blank Paper Disks (6 mm diameter, Becton, Dickinson and Company) impreg-
nated with GEP and incubated at 37 °C for 8 weeks. At the end of incubation, the
number of bacteria colonies was calculated. In total, 100 samples were prepared.
Bioﬁlm formation
To evaluate the effect of GEP on bioﬁlm formation, bacterial cultures were
raised in 15-ml screw-capped bottles with 2 ml of culture, 5 ml of media, and
0.5 ml of GEP. At the end of third week of incubation, the caps of bottles were
loosened to allow further growth ofMycobacterium at the interface. Cultures were
incubated at 37 °C for 6 weeks.
Congo red assay and cellulose optical density (OD) measurement
About 2% of Congo red was added to both the control and test samples and
continued shaking at 37 °C for 2 h. After 2 h, control and mycobacterium bioﬁlm
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cells were centrifuged at 5,000 g for 5 min, washed three times with PBS, and then
were analyzed visually for Congo red binding. OD measurement was performed at
500 nm.
Filter-aided protein sample preparation (FASP)
Proteins were concentrated on Amicon Ultra-0.5 mL 30 kDa centrifugal
ﬁlter. Trypsin digestion was performed according to a modiﬁed FASP protocol as
described by Wisniewski et al. [11]. Brieﬂy, proteins were washed with buffer
containing 8 M urea. The proteins were alkylated using iodoacetamide. Buffer was
exchanged by washing twice with 50 mM NH4HCO3, and proteins were digested
overnight with TPCK Trypsin 20233 (Thermo Scientiﬁc, USA). Then, peptides
were recovered by centrifugation and washed with 20% CH3CN. Afterward,
samples were lyophilized, redissolved in 0.1% formic acid, and analyzed by mass
spectrometry (MS).
Liquid chromatography (LC) and MS
The liquid chromatography (LC) separation of trypsin-cleaved peptides was
performed with nanoAcquity UPLC system (Waters Corporation, UK). Peptides
were loaded on a reversed-phase trap column PST C18 (Waters Corporation) at a
ﬂow rate of 15 ml/min using loading buffer of 0.1% formic acid and subsequently
separated on HSS-T3 250 mm analytical column (Waters Corporation) in 30-min
linear gradient (A: 0.1% formic acid, B: 100% CH3CN and 0.1% formic acid at a
ﬂow rate of 300 nl/min). The nano-LC was coupled online through HDMS Synapt
G2 mass spectrometer (Waters Corporation). The data was acquired usingMasslynx
version 4.1 software (Waters Corporation) in a positive ionmode. LC–MSdata were
collected using data-independent acquisition mode MSE with online ion mobility
separation. Mass range was set to 50–2,000 Da with a scan time set to 0.75 s. A
reference compound [Glu1]-Fibrinopeptide B (Waters Corporation) was continu-
ously infused (500 fmol/ml at a ﬂow rate 500 nl/min) and scanned every 30 s for
online mass spectrometer calibration purpose.
Data processing, searching, and analysis
Raw data ﬁles were processed and searched using ProteinLynx Global
SERVER (PLGS) version 3.0.1 (Waters Corporation). Mycobacterium protein
sequence database from uniprot (September 29, 2017) was used. The following
parameters were used to generate peak lists: (1) minimum intensity for precursors
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was set to 135 counts, (2) minimum intensity for fragment ions was set to 25 counts,
and (3) intensity was set to 750 counts. Processed data were analyzed using trypsin
as the cleavage protease, one missed cleavage was allowed, ﬁxed modiﬁcation was
set to carbamidomethylation of cysteines, and variable modiﬁcation was set to
oxidation of methionine. Minimum identiﬁcation criteria included one fragment ions
per peptide, three fragment ions per protein and minimum of two peptides per
protein. The false discovery rate (FDR) for peptide and protein identiﬁcation was
determined based on the search of a reversed database, which was automatically
generated using PLGS when global FDR was set to 4%.
Statistical analysis
Statistically signiﬁcant differences between the groups were examined by
the Mann–Whitney U test and Wilcoxon test; p< 0.05 was considered statistically
signiﬁcant, p< 0.09 – clear trend.
Results
GEP role in bacterial growth
We found that both GEPs inhibited the growth ofM. bovis in vitro (Figure 1).
The strongest inhibitory process was observed in M. bovis affected with MB GEP
(p= 0.030). Our results indicated that MA GEP stimulated the growth of the M.
avium subsp. avium, whereas MB GEP inhibited the process (Figure 1). Both
GEPs stimulated the growth of the M. terrae. The strongest stimulation process
was observed in M. terrae affected with MA GEP (Figure 1). Statistical signiﬁ-
cance of results is given in Table I.
GEP role in bacterial bioﬁlm formation
Cellulose is a critical component of mycobacteria bioﬁlms [9], we scraped
the bioﬁlm biomaterial and stained bioﬁlms cellulose with Congo red. We
observed that higher OD was in samples affected by GEP. OD measurement
and visual analysis conﬁrm that GEP plays an important role in bioﬁlm formation
process. In samples affected by GEP was enhanced bacterial pellicles, clumps, and
aggregates formation process. The most striking OD and visual changes were in
theM. bovis samples affected by MA GEP (Figure 2). We found thatM. bovis and
M. avium subsp. avium affected by GEP have tendency (p= 0.083) for higher OD.
GROWTH COMPOUNDS FROM MYCOBACTERIA 409
Acta Microbiologica et Immunologica Hungarica 65, 2018
Statistical signiﬁcance of results is given in Table II. We did not ﬁnd any statistically
signiﬁcance or tendency in samples with M. terrae.
GEP identiﬁcation
We analyze GEP samples using FASP method and found 22 proteins. We
found 20 proteins in MB GEP and two uncharacterized proteins in MA GEP
samples (Table III). In samples from M.terrae, we did not ﬁnd any proteins that
were identiﬁable in uniprot database.
Figure 1. Effect of MB GEP (+) and MA GEP (+) on Log CFU of M. terrae, M. avium subsp.
avium, and M.bovis. Mycobacterial samples without GEP (−) were considered to be control. GEP:
growth-affecting protein; MA GEP: GEP extracted from M. avium subsp. avium; MB GEP: GEP
extracted from M. bovis
Table I. Statistical signiﬁcance of MB GEP and MA GEP on CFU/ml of mycobacteria
Mycobacteria GEP Mean rank Mann–Whitney U Wilcoxon W z p
M. avium
subsp. avium
– 10.25 2.500 57.500 −1.623 0.121
MB GEP 5.75
– 3.75 4.500 7.500 −1.186 0.273
MA GEP 7.05
M. bovis – 11.5 0.000 55.000 −2.152 0.030
MB GEP 5.5
– 8.0 7.000 62.000 −0.646 0.606
MA GEP 6.2
Note: Mycobacterial samples without GEP (−) were considered to be control. GEP: growth-affecting
protein; MA GEP: GEP extracted from M. avium subsp. avium; MB GEP: GEP extracted from M. bovis.
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Discussion
T7S and general secretion pathways associated with mycobacteria bioﬁlm
formation and growth processes
As mentioned above in samples affected by GEP were enhanced bacterial
pellicles, clumps, and aggregates formation. The most striking OD and visual
changes were in the M. bovis samples. We found that M. bovis
and M. avium subsp. avium affected by GEP has tendency for higher OD.
Figure 2. Effect of MB GEP (+) and MA GEP (+) on bioﬁlms scraped from M. terrae, M. avium
subsp. avium, and M. bovis was evaluated by cellulose optical density (OD) measurement.
Mycobacterial samples without GEP (−) were considered to be control. GEP: growth-affecting protein;
MA GEP: GEP extracted from M. avium subsp. avium; MB GEP: GEP extracted from M. bovis
Table II. Statistical signiﬁcance of MB GEP and MA GEP on optical density of cellulose
Mycobacteria GEP Mean rank Mann–Whitney U Wilcoxon W z p
M. bovis – 1.50 0.000 3.000 −1.732 0.083
MA GEP 4.00
– 1.50 0.000 3.000 −1.732 0.083
MB GEP 4.00
M. avium
subsp. avium
– 1.50 0.000 3.000 −1.732 0.083
MB GEP 4.00
– 1.50 0.000 3.000 −1.732 0.083
MA GEP 4.00
Note: Mycobacterial samples without GEP (−) were considered to be control. GEP: growth-affecting
protein; MA GEP: GEP extracted from M. avium subsp. avium; MB GEP: GEP extracted from M. bovis.
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Proteinaceous components of the bioﬁlm matrix included secreted extracellular
proteins [10]. It is known that Mpb70, Mpb83, Mpb64, EspL, PE family and
EsxQ, ESAT-6-like proteins, and ppsD are secreted into the culture medium
and can be detectable in culture ﬁltrate. Mpb70, Mpb83, Mpb64, EspL, PE family
and EsxQ, and ESAT-6-like proteins are associated with signal peptides. All these
proteins are associated with T7S and general secretion pathways (Table III).
Our results indicate that all GEPs inhibited the growth of the M. bovis. MB
GEP inhibited the growth of the M. avium subsp. avium. The strongest inhibitory
process was observed in M. bovis affected with MB GEP. As discussed above,
mycobacteria differently react to their own and closely related slow-growing
organism-secreted proteins. The results suggest that MB GEP inhibited M. bovis
growth, while M. avium subsp. avium was stimulated by their own secreted GEP.
There is a lack of information about howmycobacteria responds to their own
and closely related, slow-growing organism-secreted proteinaceous compounds.
We identiﬁed GEP substrate and found that most of the GEP proteins associated
with the T7S pathway. Our ﬁndings suggest that these mycobacteria-secreted GEP
are involved in bioﬁlm formation and growth-affecting processes.
The addition of GEP to liquid culture medium should aid the resumption of
normal bacteria growth, which could potentially improve the diagnosis and
quantiﬁcation of mycobacterial infections. They may be involved in mycobacterial
reactivation. As well as, these proteins can act as inhibitors. Our results contribute
to a better understanding of the mechanisms underlying mycobacterial bioﬁlm
formation and growth-affecting processes and better characterization of myco-
bacterial proteins and their functions.
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